Nutra Pharma Corp (NPHC) Long-Term Investments (2019 - 2026)

Nutra Pharma has disclosed Long-Term Investments across 8 years of filings, most recently posting $91244.0 for Q2 2026.

• In Q2 2026, Long-Term Investments fell 15.26% year-over-year to $91244.0; the TTM figure through Jun 2026 stood at $91244.0 (down 15.26% YoY), while the FY2025 annual figure was $99170.0, down 13.52% from the prior year.
• Long-Term Investments came in at $91244.0 for Q2 2026 at Nutra Pharma, down from $93790.0 in the prior quarter.
• In the past five years, Long-Term Investments ranged from a high of $125170.0 in Q4 2023 to a low of $80570.0 in Q4 2022.
• Average Long-Term Investments over 5 years is $100093.6, with a median of $98825.0 recorded in 2022.
• Year-over-year, Long-Term Investments retreated 18.52% in 2022 and soared 55.36% in 2023.
• Over 5 years, Long-Term Investments stood at $80570.0 in 2022, then soared by 55.36% to $125170.0 in 2023, then decreased by 8.39% to $114670.0 in 2024, then retreated by 13.52% to $99170.0 in 2025, then fell by 7.99% to $91244.0 in 2026.
• Per Business Quant data, the three most recent Long-Term Investments figures were $91244.0 in Q2 2026, $93790.0 in Q1 2026, and $99170.0 in Q4 2025.